SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-007627
Filing Date
2019-05-01
Accepted
2019-05-01 18:33:19
Documents
1
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 4086
  Complete submission text file 0001213900-19-007627.txt   5519
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 543 LOMBARD ST SAN FRANCISCO CA 94133
Business Address
TOTH ROBERT JOSEPH JR (Reporting) CIK: 0001585020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 19789125